Listing 1 - 6 of 6 |
Sort by
|
Choose an application
Poised at the convergence of most catabolic and anabolic pathways, mitochondria are the center of heterotrophic aerobic life, representing a hub in the overall metabolic network of cells. The energetic functions performed by mitochondria face the unavoidable redox hurdle of handling huge amounts of oxygen while keeping its own as well as the cellular redox environment under control. Reactive oxygen species (ROS) are produced in the respiratory chain as a result of the energy supplying function of mitochondria. Originally considered an unavoidable by-product of oxidative phosphorylation, ROS have become crucial signaling molecules when their levels are kept within physiological range. This occurs when their production and scavenging are balanced within mitochondria and cells. Mitochondria-generated hydrogen peroxide can act as a signaling molecule within mitochondria or in the cytoplasm, affecting multiple networks that control, for example, cell cycle, stress response, cell migration and adhesion, energy metabolism, redox balance, cell contraction, and ion channels. However, under pathophysiological conditions, excessive ROS levels can happen due to either overproduction, overwhelming of antioxidant defenses, or both. Under oxidative stress, detrimental effects of ROS include oxidation of protein, lipids, and nucleic acids; mitochondrial depolarization and calcium overload; and cell-wide oscillations mediated by ROS-induced ROS release mechanisms. Mitochondrial dysfunction is central in the pathogenesis of numerous human maladies including cardiomyopathies and neurodegeneration. Diseases characterized by altered nutrient metabolism, such as diabetes and cancer, exhibit elevated ROS levels. These may contribute to pathogenesis by increasing DNA mutation, affecting regulatory signaling and transcription, and promoting inflammation. Under metabolic stress, several ionic channels present in the inner and outer mitochondrial membranes can have pro-life and -death effects. In the present E-book, based on the Frontiers Research Topic entitled: "Mitochondria: Hubs of cellular signaling, energetics and redox balance", we address one of the fundamental questions that the field of ROS biology faces today: how do mitochondria accomplish a reliable energy provision and at the same time keep ROS levels within physiological, non-harming, limits but crucial for cellular signaling function? Additionally, and within the perspective of mitochondria as signaling-energetic hubs in the extensive cellular metabolic network, we ask how can their collective dynamics scale from the subcellular to the cellular, tissue and organ levels to affect function in health and disease.
redox and energetic compartmentation --- light- and anesthetics-induced cardioprotection --- redox metabolism and signaling --- hypertrophic and diabetic cardiomyopathies --- skeletal-cardiac muscle and brain protection --- ketone bodies --- post-translational modifications --- redox aging --- lipid catabolism --- necroptosis
Choose an application
Poised at the convergence of most catabolic and anabolic pathways, mitochondria are the center of heterotrophic aerobic life, representing a hub in the overall metabolic network of cells. The energetic functions performed by mitochondria face the unavoidable redox hurdle of handling huge amounts of oxygen while keeping its own as well as the cellular redox environment under control. Reactive oxygen species (ROS) are produced in the respiratory chain as a result of the energy supplying function of mitochondria. Originally considered an unavoidable by-product of oxidative phosphorylation, ROS have become crucial signaling molecules when their levels are kept within physiological range. This occurs when their production and scavenging are balanced within mitochondria and cells. Mitochondria-generated hydrogen peroxide can act as a signaling molecule within mitochondria or in the cytoplasm, affecting multiple networks that control, for example, cell cycle, stress response, cell migration and adhesion, energy metabolism, redox balance, cell contraction, and ion channels. However, under pathophysiological conditions, excessive ROS levels can happen due to either overproduction, overwhelming of antioxidant defenses, or both. Under oxidative stress, detrimental effects of ROS include oxidation of protein, lipids, and nucleic acids; mitochondrial depolarization and calcium overload; and cell-wide oscillations mediated by ROS-induced ROS release mechanisms. Mitochondrial dysfunction is central in the pathogenesis of numerous human maladies including cardiomyopathies and neurodegeneration. Diseases characterized by altered nutrient metabolism, such as diabetes and cancer, exhibit elevated ROS levels. These may contribute to pathogenesis by increasing DNA mutation, affecting regulatory signaling and transcription, and promoting inflammation. Under metabolic stress, several ionic channels present in the inner and outer mitochondrial membranes can have pro-life and -death effects. In the present E-book, based on the Frontiers Research Topic entitled: "Mitochondria: Hubs of cellular signaling, energetics and redox balance", we address one of the fundamental questions that the field of ROS biology faces today: how do mitochondria accomplish a reliable energy provision and at the same time keep ROS levels within physiological, non-harming, limits but crucial for cellular signaling function? Additionally, and within the perspective of mitochondria as signaling-energetic hubs in the extensive cellular metabolic network, we ask how can their collective dynamics scale from the subcellular to the cellular, tissue and organ levels to affect function in health and disease.
redox and energetic compartmentation --- light- and anesthetics-induced cardioprotection --- redox metabolism and signaling --- hypertrophic and diabetic cardiomyopathies --- skeletal-cardiac muscle and brain protection --- ketone bodies --- post-translational modifications --- redox aging --- lipid catabolism --- necroptosis
Choose an application
Poised at the convergence of most catabolic and anabolic pathways, mitochondria are the center of heterotrophic aerobic life, representing a hub in the overall metabolic network of cells. The energetic functions performed by mitochondria face the unavoidable redox hurdle of handling huge amounts of oxygen while keeping its own as well as the cellular redox environment under control. Reactive oxygen species (ROS) are produced in the respiratory chain as a result of the energy supplying function of mitochondria. Originally considered an unavoidable by-product of oxidative phosphorylation, ROS have become crucial signaling molecules when their levels are kept within physiological range. This occurs when their production and scavenging are balanced within mitochondria and cells. Mitochondria-generated hydrogen peroxide can act as a signaling molecule within mitochondria or in the cytoplasm, affecting multiple networks that control, for example, cell cycle, stress response, cell migration and adhesion, energy metabolism, redox balance, cell contraction, and ion channels. However, under pathophysiological conditions, excessive ROS levels can happen due to either overproduction, overwhelming of antioxidant defenses, or both. Under oxidative stress, detrimental effects of ROS include oxidation of protein, lipids, and nucleic acids; mitochondrial depolarization and calcium overload; and cell-wide oscillations mediated by ROS-induced ROS release mechanisms. Mitochondrial dysfunction is central in the pathogenesis of numerous human maladies including cardiomyopathies and neurodegeneration. Diseases characterized by altered nutrient metabolism, such as diabetes and cancer, exhibit elevated ROS levels. These may contribute to pathogenesis by increasing DNA mutation, affecting regulatory signaling and transcription, and promoting inflammation. Under metabolic stress, several ionic channels present in the inner and outer mitochondrial membranes can have pro-life and -death effects. In the present E-book, based on the Frontiers Research Topic entitled: "Mitochondria: Hubs of cellular signaling, energetics and redox balance", we address one of the fundamental questions that the field of ROS biology faces today: how do mitochondria accomplish a reliable energy provision and at the same time keep ROS levels within physiological, non-harming, limits but crucial for cellular signaling function? Additionally, and within the perspective of mitochondria as signaling-energetic hubs in the extensive cellular metabolic network, we ask how can their collective dynamics scale from the subcellular to the cellular, tissue and organ levels to affect function in health and disease.
redox and energetic compartmentation --- light- and anesthetics-induced cardioprotection --- redox metabolism and signaling --- hypertrophic and diabetic cardiomyopathies --- skeletal-cardiac muscle and brain protection --- ketone bodies --- post-translational modifications --- redox aging --- lipid catabolism --- necroptosis --- redox and energetic compartmentation --- light- and anesthetics-induced cardioprotection --- redox metabolism and signaling --- hypertrophic and diabetic cardiomyopathies --- skeletal-cardiac muscle and brain protection --- ketone bodies --- post-translational modifications --- redox aging --- lipid catabolism --- necroptosis
Choose an application
This collection of articles provides an overview of the current and future methods for applying a personalized medicine approach to the diagnosis, management, and treatment of autism spectrum disorder.
Medicine --- Neurosciences --- fecal metabolites --- ASD --- microbiome --- gastrointestinal symptoms --- Fisher Discriminant Analysis --- digital biomarkers --- wearables --- time series analysis --- autism --- social dyads --- socio-motor parameters --- network connectivity --- non-linear complex dynamics --- stochastic analysis --- autism spectrum disorders --- copy number variants --- females --- Array-Comparative Genomic Hybridization (Array-CGH) --- autism spectrum disorder --- Ehlers-Danlos syndrome --- hypermobility spectrum disorders --- autonomic disorder --- mast cell activation syndrome --- genetic testing --- chromosomal microarray analysis --- whole exome sequencing --- whole genome sequencing --- clinical utility --- polygenic risk scores --- Temple Grandin --- biomarker --- omics --- precision medicine --- proteomics --- transcriptomics --- epigenetics --- metabolomics --- patient stratification --- mitochondria --- oxidative stress --- prenatal environment --- immune dysfunction --- immunoglobulin G --- intravenous immunoglobulin --- energy metabolism --- fatty acid oxidation --- acyl-carnitines --- resveratrol --- integrative --- model --- concomitant --- condition --- disorder --- autism spectrum disorder (ASD) --- genomics --- personalized treatment strategy --- single nucleotide polymorphisms --- clinical decision support tool --- ADHD --- PANDAS --- OCD --- anxiety --- folate receptor alpha --- folates --- pregnancy --- brain development --- fetal development --- cobalamin --- glutathione --- methylation --- methylcobalamin --- redox metabolism --- locked-in network syndrome --- resting-state functional magnetic resonance imaging --- temporal lobe epilepsy --- amygdala --- brain --- COVID-19 --- children --- cytokines --- flavonoids --- inflammation --- luteolin --- mast cells --- microglia --- SARS-CoV-2 --- stress --- nutraceuticals --- survey --- vitamins --- minerals --- B12 --- folinic acid --- quality of life --- parents --- intervention --- systematic review --- medical claims --- logistic regression analysis --- retrospective analysis --- associated risk --- monoamine neurotransmitters --- neurotransmitter deficiency --- cerebral folate deficiency --- folate receptor alpha autoantibodies --- leucovorin --- α-amylase --- cortisol --- heart rate variability --- neuromodulation --- sleep anxiety --- transdermal electrical neuromodulation --- neurostimulation --- fecal metabolites --- ASD --- microbiome --- gastrointestinal symptoms --- Fisher Discriminant Analysis --- digital biomarkers --- wearables --- time series analysis --- autism --- social dyads --- socio-motor parameters --- network connectivity --- non-linear complex dynamics --- stochastic analysis --- autism spectrum disorders --- copy number variants --- females --- Array-Comparative Genomic Hybridization (Array-CGH) --- autism spectrum disorder --- Ehlers-Danlos syndrome --- hypermobility spectrum disorders --- autonomic disorder --- mast cell activation syndrome --- genetic testing --- chromosomal microarray analysis --- whole exome sequencing --- whole genome sequencing --- clinical utility --- polygenic risk scores --- Temple Grandin --- biomarker --- omics --- precision medicine --- proteomics --- transcriptomics --- epigenetics --- metabolomics --- patient stratification --- mitochondria --- oxidative stress --- prenatal environment --- immune dysfunction --- immunoglobulin G --- intravenous immunoglobulin --- energy metabolism --- fatty acid oxidation --- acyl-carnitines --- resveratrol --- integrative --- model --- concomitant --- condition --- disorder --- autism spectrum disorder (ASD) --- genomics --- personalized treatment strategy --- single nucleotide polymorphisms --- clinical decision support tool --- ADHD --- PANDAS --- OCD --- anxiety --- folate receptor alpha --- folates --- pregnancy --- brain development --- fetal development --- cobalamin --- glutathione --- methylation --- methylcobalamin --- redox metabolism --- locked-in network syndrome --- resting-state functional magnetic resonance imaging --- temporal lobe epilepsy --- amygdala --- brain --- COVID-19 --- children --- cytokines --- flavonoids --- inflammation --- luteolin --- mast cells --- microglia --- SARS-CoV-2 --- stress --- nutraceuticals --- survey --- vitamins --- minerals --- B12 --- folinic acid --- quality of life --- parents --- intervention --- systematic review --- medical claims --- logistic regression analysis --- retrospective analysis --- associated risk --- monoamine neurotransmitters --- neurotransmitter deficiency --- cerebral folate deficiency --- folate receptor alpha autoantibodies --- leucovorin --- α-amylase --- cortisol --- heart rate variability --- neuromodulation --- sleep anxiety --- transdermal electrical neuromodulation --- neurostimulation
Choose an application
This collection of articles provides an overview of the current and future methods for applying a personalized medicine approach to the diagnosis, management, and treatment of autism spectrum disorder.
Medicine --- Neurosciences --- fecal metabolites --- ASD --- microbiome --- gastrointestinal symptoms --- Fisher Discriminant Analysis --- digital biomarkers --- wearables --- time series analysis --- autism --- social dyads --- socio-motor parameters --- network connectivity --- non-linear complex dynamics --- stochastic analysis --- autism spectrum disorders --- copy number variants --- females --- Array-Comparative Genomic Hybridization (Array-CGH) --- autism spectrum disorder --- Ehlers-Danlos syndrome --- hypermobility spectrum disorders --- autonomic disorder --- mast cell activation syndrome --- genetic testing --- chromosomal microarray analysis --- whole exome sequencing --- whole genome sequencing --- clinical utility --- polygenic risk scores --- Temple Grandin --- biomarker --- omics --- precision medicine --- proteomics --- transcriptomics --- epigenetics --- metabolomics --- patient stratification --- mitochondria --- oxidative stress --- prenatal environment --- immune dysfunction --- immunoglobulin G --- intravenous immunoglobulin --- energy metabolism --- fatty acid oxidation --- acyl-carnitines --- resveratrol --- integrative --- model --- concomitant --- condition --- disorder --- autism spectrum disorder (ASD) --- genomics --- personalized treatment strategy --- single nucleotide polymorphisms --- clinical decision support tool --- ADHD --- PANDAS --- OCD --- anxiety --- folate receptor alpha --- folates --- pregnancy --- brain development --- fetal development --- cobalamin --- glutathione --- methylation --- methylcobalamin --- redox metabolism --- locked-in network syndrome --- resting-state functional magnetic resonance imaging --- temporal lobe epilepsy --- amygdala --- brain --- COVID-19 --- children --- cytokines --- flavonoids --- inflammation --- luteolin --- mast cells --- microglia --- SARS-CoV-2 --- stress --- nutraceuticals --- survey --- vitamins --- minerals --- B12 --- folinic acid --- quality of life --- parents --- intervention --- systematic review --- medical claims --- logistic regression analysis --- retrospective analysis --- associated risk --- monoamine neurotransmitters --- neurotransmitter deficiency --- cerebral folate deficiency --- folate receptor alpha autoantibodies --- leucovorin --- α-amylase --- cortisol --- heart rate variability --- neuromodulation --- sleep anxiety --- transdermal electrical neuromodulation --- neurostimulation --- n/a
Choose an application
This collection of articles provides an overview of the current and future methods for applying a personalized medicine approach to the diagnosis, management, and treatment of autism spectrum disorder.
fecal metabolites --- ASD --- microbiome --- gastrointestinal symptoms --- Fisher Discriminant Analysis --- digital biomarkers --- wearables --- time series analysis --- autism --- social dyads --- socio-motor parameters --- network connectivity --- non-linear complex dynamics --- stochastic analysis --- autism spectrum disorders --- copy number variants --- females --- Array-Comparative Genomic Hybridization (Array-CGH) --- autism spectrum disorder --- Ehlers-Danlos syndrome --- hypermobility spectrum disorders --- autonomic disorder --- mast cell activation syndrome --- genetic testing --- chromosomal microarray analysis --- whole exome sequencing --- whole genome sequencing --- clinical utility --- polygenic risk scores --- Temple Grandin --- biomarker --- omics --- precision medicine --- proteomics --- transcriptomics --- epigenetics --- metabolomics --- patient stratification --- mitochondria --- oxidative stress --- prenatal environment --- immune dysfunction --- immunoglobulin G --- intravenous immunoglobulin --- energy metabolism --- fatty acid oxidation --- acyl-carnitines --- resveratrol --- integrative --- model --- concomitant --- condition --- disorder --- autism spectrum disorder (ASD) --- genomics --- personalized treatment strategy --- single nucleotide polymorphisms --- clinical decision support tool --- ADHD --- PANDAS --- OCD --- anxiety --- folate receptor alpha --- folates --- pregnancy --- brain development --- fetal development --- cobalamin --- glutathione --- methylation --- methylcobalamin --- redox metabolism --- locked-in network syndrome --- resting-state functional magnetic resonance imaging --- temporal lobe epilepsy --- amygdala --- brain --- COVID-19 --- children --- cytokines --- flavonoids --- inflammation --- luteolin --- mast cells --- microglia --- SARS-CoV-2 --- stress --- nutraceuticals --- survey --- vitamins --- minerals --- B12 --- folinic acid --- quality of life --- parents --- intervention --- systematic review --- medical claims --- logistic regression analysis --- retrospective analysis --- associated risk --- monoamine neurotransmitters --- neurotransmitter deficiency --- cerebral folate deficiency --- folate receptor alpha autoantibodies --- leucovorin --- α-amylase --- cortisol --- heart rate variability --- neuromodulation --- sleep anxiety --- transdermal electrical neuromodulation --- neurostimulation --- n/a
Listing 1 - 6 of 6 |
Sort by
|